The invention relates to difluorobenzo-1,3-dioxoles, to a process for their preparation, and to their use for preparing medicaments and crop protection agents.
|
##STR00003##
wherein
R1 is C1-C12-alkyl, C1-C12-fluoroalkyl, C1-C12-alkoxy, C1-C12-fluoroalkoxy, cyano, nitro, iodine, bromine, chlorine or fluorine and
n is 0, 1, 2 or 3.
2. The compound according to
3. A process for preparing compounds according to
##STR00004##
wherein R1 and n are defined as in
with thiophosgene in the presence of an aqueous-acidic medium thereby forming isothiocyanates corresponding structurally to the formula (I) as set forth in
4. The process according to
5. A process for preparing isothiocyanates corresponding structurally to the formula (I) as set forth in
##STR00005##
wherein R1 and n are defined as in
with thiocarbamic acid derivatives.
6. The process according to
7. A process for preparing isothiocyanates corresponding structurally to the formula (I) as set forth in
##STR00006##
wherein R1 and n are defined as in
8. A process for preparing isothiocyanates corresponding structurally to the formula (I) as set forth in
##STR00007##
wherein R1 and n are defined as in
first with carbon disulphide in the presence of an alkali base and subsequently with phosgene.
9. A process for preparing isothiocyanates corresponding structurally to the formula (I) as set forth in
##STR00008##
wherein R1 and n are defined as in
first with carbon disulphide in the presence of an alkali base and subsequently with oxalyl chloride.
|
The invention relates to difluorobenzo-1,3-dioxoles, to a process for their preparation, and to their use for preparing medicaments and crop protection agents.
Difluorobenzo-1,3-dioxoles are valuable building blocks in active agrochemical and pharmaceutical ingredients; see also WO 02/81453, in particular example 321. In order to be able to introduce the difluorobenzo-1,3-dioxole building block into the active ingredient molecule, 5-bromodifluorobenzo-1,3-dioxole is subjected to a palladium-catalysed transformation which is expensive from an industrial viewpoint. There is therefore a need to provide difluorobenzo-1,3-dioxoles which can be incorporated in a simple manner into such active ingredient molecules via a functionality intrinsic to them and which can be prepared in a simple and efficient process.
Compounds of the formula (I) have now been found
##STR00001##
in which
The compounds of the formula (I) can be converted in a simple manner known from WO 02/81453 to the thioxoimidazolinones described there.
A process has also been found for preparing compounds of the formula (I), which is characterized in that compounds of the formula (II)
##STR00002##
in which R1 and n are each as defined above are converted in a manner known in principle to the corresponding isothiocyanates.
Preferred processes include:
The reaction with thiophosgene is particularly preferred, and the reaction is advantageously effected in aqueous-acidic medium.
The processes mentioned are sufficiently well known in terms of principle from the literature. The compounds of the formula (II) used as starting compounds are either known from the literature or can be prepared analogously to the literature. It is to be regarded as particularly surprising that the difluorobenzodioxole function which is known to be labile and thermally sensitive and sensitive towards halogen exchange is not attacked to a significant extent by the reaction.
The scope of the invention embraces all radical definitions, parameters and illustrations above and listed hereinbelow, in general or within areas of preference, in any combination with one another, i.e. also between the particular areas and areas of preference.
Alkyl and alkoxy are each independently a straight-chain, cyclic, branched or unbranched alkyl and alkoxy radical respectively, and the radicals mentioned may optionally be further substituted by C1-C4-alkoxy radicals.
C1-C12-Alkyl is, for example and with preference, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, neopentyl, 1-ethylpropyl, cyclohexyl, cyclopentyl, n-hexyl, n-heptyl, n-octyl, n-decyl and n-dodecyl.
C1-C12-Alkoxy is, for example and with preference, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, tert-butoxy, n-pentoxy, cyclohexoxy, cyclopentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-decoxy and n-dodecoxy
Fluoroalkyl and fluoroalkoxy are in each case independently a straight-chain, cyclic, branched or unbranched alkyl radical and alkoxy radical respectively, each of which is substituted singly, multiply or fully by fluorine atoms.
For example, C1-C12-fluoroalkyl is trifluoromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, nonafluorobutyl, heptafluoroisopropyl, perfluorooctyl and perfluorododecyl.
For example, C1-C12-fluoroalkoxy is trifluoromethoxy, 2,2,2-trifluoroethoxy, pentafluoroethoxy, nonafluorobutoxy, heptafluoroisopropoxy, perfluorooctoxy and perfluorododecoxy.
The preferred substitution patterns for the compounds of the formulae (I) and (II) are defined hereinbelow:
A particularly preferred compound of the formula (I) is 5-isothiocyanato-2,2-difluorobenzo-1,3-dioxole.
A particularly preferred compound of the formula (II) is 5-amino-2,2-difluorobenzo-1,3-dioxole.
The inventive compounds of the formula (I) are suitable in particular for preparing pharmaceuticals, medicines, agrochemicals or intermediates thereof. Compounds of the formula (I) may be used preferably for the preparation of thioxoimidazolinones, in particular for those such as are described in WO 02/81453.
Preparation of 5-isothiocyanato-2,2-difluorobenzo[1,3]-dioxole:
34.6 g of 5-amino-2,2-difluorobenzodioxole were added dropwise to a solution of 90 ml of conc. hydrochloric acid in 350 ml of water. The mixture was stirred for a further 30 minutes and then 27 g of thiophosgene were metered in rapidly. The mixture was stirred at the given temperature for a further 3 hours, the almost colourless suspension was admixed with 150 ml of dichloromethane and the dichloromethane was removed. The crude product was distilled at 45 mbar. 28 g (=89% of theory) were obtained as a colourless to yellowish liquid.
Boiling point: 136° C./45 mbar.
1H NMR (400 MHz, CDCl6): 6.96 (m, 2H), 7.02 (m, 1H)
Marhold, Albrecht, Pleschke, Axel
Patent | Priority | Assignee | Title |
11581487, | Apr 26 2017 | OTI Lumionics Inc. | Patterned conductive coating for surface of an opto-electronic device |
Patent | Priority | Assignee | Title |
4536587, | Jun 21 1980 | Bayer Aktiengesellschaft | Combating pests with substituted benzoyl-(thio)ureas |
4743611, | Jul 02 1986 | Wyeth | Naphthalenylsulfonylimidazolidinediones and their thioxo analogs useful as aldose reductase inhibitors |
5070098, | Jan 24 1990 | Bayer Aktiengesellschaft | Substituted pyrazoline derivatives, pesticidal compositions and use |
5260460, | Oct 07 1991 | Bayer Aktiengesellschaft | Process for the preparation of fluorine-substituted aminobenzodioxoles and -benzodioxanes and new intermediates |
5663189, | Jul 01 1993 | Procter & Gamble Company, The | 2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists |
20040116417, | |||
DE2848531, | |||
WO2081453, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 11 2005 | LANXESS Deutschland GmbH | (assignment on the face of the patent) | / | |||
Jun 09 2005 | PLESCHKE, AXEL | LANXESS Deutschland GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016658 | /0312 | |
Jun 09 2005 | MARHOLD, ALBRECHT | LANXESS Deutschland GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016658 | /0312 |
Date | Maintenance Fee Events |
Jan 21 2011 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Apr 03 2015 | REM: Maintenance Fee Reminder Mailed. |
Aug 21 2015 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Aug 21 2010 | 4 years fee payment window open |
Feb 21 2011 | 6 months grace period start (w surcharge) |
Aug 21 2011 | patent expiry (for year 4) |
Aug 21 2013 | 2 years to revive unintentionally abandoned end. (for year 4) |
Aug 21 2014 | 8 years fee payment window open |
Feb 21 2015 | 6 months grace period start (w surcharge) |
Aug 21 2015 | patent expiry (for year 8) |
Aug 21 2017 | 2 years to revive unintentionally abandoned end. (for year 8) |
Aug 21 2018 | 12 years fee payment window open |
Feb 21 2019 | 6 months grace period start (w surcharge) |
Aug 21 2019 | patent expiry (for year 12) |
Aug 21 2021 | 2 years to revive unintentionally abandoned end. (for year 12) |